Healthcare Roundup – Sorrento up 15% on encouraging COVIDTRAP data, Novavax scores defense funding for COVID-19 vaccine Jun 5, 2020 Life Science
Healthcare Roundup – Inovio to begin Phase 1/2 trial of COVID-19 DNA vaccine, Roche’s severe COVID-19 test scores FDA approval Jun 4, 2020 Life Science
Fosun to Merge Two Cosmetics Brands With China’s Biggest Retail Conglomerate Jun 4, 2020 Life Science
Healthcare Roundup – Novavax secures source for COVID-19 vaccine adjuvant, Pfizer announces publication of successful abrocitinib study in atopic dermatitis Jun 3, 2020 Life Science
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors Jun 3, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of Philips monitors for COVID-19 use, AgeX Therapeutics +12% on ESI 053 deal for COVID-19 Jun 2, 2020 Life Science
Healthcare Roundup – FDA OKs emergency use of Siemens COVID-19 blood test, Short regimen of Gilead’s remdesivir beats standard-of-care in COVID-19 study Jun 1, 2020 Life Science
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites May 28, 2020 Life Science
Fosun Int’l Bets on China’s Unquenchable Thirst via Majority Stake in Jinhui Liquor May 27, 2020 Life Science
EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer May 27, 2020 Life Science
Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers May 27, 2020 Life Science
Healthcare Roundup – Merck jumps into COVID-19 arena with three initiatives, Gilead picks up an upgrade on remdesivir upside May 26, 2020 Life Science
Healthcare Roundup – Novavax starts clinical trial of COVID-19 vaccine, Sanofi to shed 20.6% stake in Regeneron May 25, 2020 Life Science
Healthcare Roundup – FDA OKs Takeda’s brigatinib, Pfizer urges noteholders to reject offer by Huguenot Bond Liquidity May 23, 2020 Life Science
Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101 May 22, 2020 Life Science
